buddlejasaponin iv has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asnaashari, S; Fathiazad, F; Hamedeyazdan, S; Naseri, N; Sharifi, S | 1 |
| Chung, WY; Hwang, YS; Kim, EC; Kim, J; Park, HJ; Park, KK | 1 |
2 other study(ies) available for buddlejasaponin iv and Cancer of Mouth
| Article | Year |
|---|---|
Anticancer effect of buddlejasaponin IV and buddlejasaponin IVa from Clinopodium umbrosum on oral cancer cells (HN-5).
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Endothelial Cells; Humans; Lamiaceae; Mouth Neoplasms; Plant Extracts; Saponins | 2022 |
Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes.
Topics: Alphapapillomavirus; Antineoplastic Agents, Phytogenic; Apiaceae; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Humans; Keratinocytes; Mitochondria; Mouth Mucosa; Mouth Neoplasms; Nuclear Proteins; Phosphorylation; Phytotherapy; Plant Extracts; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Salivary Proline-Rich Proteins; Saponins; Triterpenes; Tumor Necrosis Factors; Tumor Protein p73; Tumor Suppressor Proteins | 2011 |